PICO Holdings Inc. (PICO) Jumps 5.26% on December 21

Equities Staff  |

PICO Holdings Inc. (PICO) was among the biggest gainers on the Russell 2000 for Monday December 21 as the stock popped 5.26% to $9.80, representing a gain of $0.49 per share. Some 725,784 shares traded hands on 2,270 trades, compared with an average daily volume of 129,802 shares out of a total float of 23.02 million. The stock opened at $9.25 and traded with an intraday range of $9.85 to $8.95.

After today's gains, PICO Holdings Inc. reached a market cap of $225.57 million. PICO Holdings Inc. has had a trading range between $19.38 and $8.95 over the last year, and it had a 50-day SMA of $10.26 and a 200-day SMA of $13.63.

PICO Holdings Inc is a diversified holding company. It is engaged in developing water resources and water storage operations, development of homebuilding and land, operating a canola seed crushing plant, and acquiring & finance business.

PICO Holdings Inc. is based out of La Jolla, CA and has some 281 employees. Its CEO is John R. Hart.

For a complete fundamental analysis analysis of PICO Holdings Inc., check out Equities.com’s Stock Valuation Analysis report for PICO. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update. Mr. Corin discusses the company's recent acquisition of Metastron, a radiopharmaceutical for cancer bone pain. Q BioMed is dedicated to providing these target assets; strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential, enabling them to provide products to patients in need?.

Emerging Growth

Investview Inc

Investview Inc is an investor technology and education company. It provides products that allow the individual investor to find, analyze, track, and manage their portfolio.